Association is bidding to own and manage the .pharmacy domain name; a decision is expected this summer
The National Assn. of Boards of Pharmacy (NABP; Mt. Prospect, IL) has just updated its ongoing survey of online sellers of drugs, finding that of 10,082 sites surveyed through April, just under 97% of them fail one or more criteria for legitimate pharmaceutical dispensing in the US. Nearly 9,000 of them do not require a valid prescription; almost 5,000 offer foreign or non-FDA-approved drugs, 2,347 have a physical address outside the US (NABP requires those dispensing ethical products to be located in the US) and—amazingly—1,123 dispense controlled substances, which violates a host of DEA and other regulators’ rules. Currently, there are 82 sites accredited by NABP as Verified Internet Pharmacy Practice Sites (VIPPS) or the related Vet-VIPPS for veterinary practices.
Last June, NABP applied to the Internet Corp. for Assigned Names and Numbers (ICANN) to own and manage a new “generic top-level domain” (gTLD), .pharmacy. (TLDs are the phrase following the dot in a website URL, such as .com, .gov, .org, etc.; ICANN is in the process of allowing thousands of new TLDs to be specified.) gTLD owners pay a licensing fee to ICANN and need to be vetted by that organization. According to NABP, there has been some grumbling that NABP is taking on a global responsibility that might lead to US-based online pharmacies getting preferential treatment—but the international ICANN organization is itself amply represented globally (and would therefore be expected to account for multinational concerns). Moreover, NABP itself has affiliate relationships in other countries (notably Canada), and has sought and received support from several non-US organizations. Eli Lilly, Merck and about a dozen other pharma companies have ponied up several hundred thousand dollars to support NABP’s effort.
“Mindful of the international spread of unapproved, substandard, and counterfeit medicine, and the contributing role that illegal online drug sellers play, NABP it taking steps to establish an online space exclusively for legitimate Internet pharmacies and other trustworthy prescription drug-related organizations,” the group says in its latest report. The ICANN evaluation process is intricate and deliberate; NABP expects a decision this summer. Owning .pharmacy won’t put illicit sellers out of business, but should provide better clarity to consumers. It remains to be seen how NABP might regulate legitimate online pharmacies globally.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.